The role of (18)F-FDG PET/CT in patients with diffuse large B-cell lymphoma after radioimmunotherapy using (131)I-rituximab as consolidation therapy

PURPOSE: To evaluate the prognostic value of pretreatment (18)F-FDG PET/CT after consolidation therapy of (131)I-rituximab in patients with diffuse large B-cell lymphoma (DLBCL) who had acquired complete remission after receiving chemotherapy. METHODS: Patients who were diagnosed with DLBCL via hist...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Joon Ho, Lim, Ilhan, Byun, Byung Hyun, Kim, Byung Il, Choi, Chang Woon, Kang, Hye Jin, Shin, Dong-Yeop, Lim, Sang Moo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512194/
https://www.ncbi.nlm.nih.gov/pubmed/36156599
http://dx.doi.org/10.1371/journal.pone.0273839

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512194/
https://www.ncbi.nlm.nih.gov/pubmed/36156599
http://dx.doi.org/10.1371/journal.pone.0273839

Ejemplares similares